Log in
Enquire now
‌

US Patent 9453225 Multiple exon skipping compositions for DMD

Patent 9453225 was granted and assigned to Sarepta Therapeutics on September, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Sarepta Therapeutics
Sarepta Therapeutics
0
Current Assignee
Sarepta Therapeutics
Sarepta Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
94532250
Patent Inventor Names
Peter Sazani0
Ryszard Kole0
Date of Patent
September 27, 2016
0
Patent Application Number
148575900
Date Filed
September 17, 2015
0
Patent Citations Received
‌
US Patent 11932851 Exon skipping compositions for treating muscular dystrophy
0
Patent Primary Examiner
‌
Jennifer McDonald
0
Patent abstract

Provided are antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping, and methods of use thereof to treat muscular dystrophy.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9453225 Multiple exon skipping compositions for DMD

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.